Bio-Techne (TECH) Operating Expenses (2009 - 2026)

Bio-Techne has reported Operating Expenses for 18 years, with the latest figure at $132.8 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 24.48% year-over-year to $132.8 million; the trailing twelve-month figure through Mar 2026 stood at $632.7 million (up 1.58% YoY), and the FY2025 full-year result was $688.0 million, up 22.2% from the prior year.
• Operating Expenses for Q1 2026 stood at $132.8 million, down from $136.8 million in the prior quarter.
• The five-year high for Operating Expenses was $222.7 million in Q2 2025, with the low at $110.2 million in Q2 2023.
• Average Operating Expenses over 5 years is $139.0 million, with a median of $136.8 million recorded in 2025.
• Year-over-year, Operating Expenses soared 42.98% in 2024 and retreated 24.48% in 2026.
• Tracing TECH's Operating Expenses over 5 years: stood at $115.5 million in 2022, then climbed by 20.02% to $138.6 million in 2023, then increased by 5.69% to $146.5 million in 2024, then declined by 6.59% to $136.8 million in 2025, then decreased by 2.94% to $132.8 million in 2026.
• The last three Operating Expenses figures came in at $132.8 million (Q1 2026), $136.8 million (Q4 2025), and $140.5 million (Q3 2025), per Business Quant data.

Peer Comparison